Anya Biopharm Inc.

NT$26.20As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7776Healthcare
Country Taiwan
PE (Fwd) •••
TSR 2Y CAGR (27.52%)
Div yield —
ROE (13.14%)
Pharmaceutical Preparations
Beta (5Y) (0.18)
PE TTM —
TSR TTM (45.81%)
Mkt cap NT$1.286B
ROIC (15.13%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$25
(2.89%)
(11.71%)
Hold 10|8|2|9|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.60
0.61
0.65
0.70
36.95%
32.82%
31.96%
28.45%
RevenueNT$M
79.80
78.40
81.97
85.21
0.27%
(0.24%)
5.77%
13.15%
Peers (US$38.85M)
Cap (US$)
PE
48.71M
25.21x
Capital
TTM
5Y
10Y
Leveragex
0.096
(0.032)
(0.031)
EBIT/Intx
1.078
0.052
0.058
Own earn%
(84.24)
164.48
157.65
Sh yield%
28.30
34.35
34.15
Owners
Insiders/Inst%
1.90
58.10
Short interest%
4.13
SBC / revenue%
3.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
20–24
$1 testx
−0.3
Incr. ROIC%
7